Michael Gerhard Kaul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael Gerhard Kaul has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Caroline Jung
Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publicationsG. Adam
Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publicationsGerhard Adam
Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publicationsHarald Ittrich
Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publicationsJohannes Salamon
Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publications- Tobias Knopp
Institute for Biomedical Imaging Hamburg University of Technology Hamburg Germany
2 shared publications
Latest Publications
- Open Access
- 1 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Pulmonary blood volume estimation in mice by magnetic particle imaging and magnetic resonance imaging
This methodical work describes the measurement and calculation of pulmonary blood volume in mice based on two imaging techniques namely by using magnetic particle imaging (MPI) and cardiac magnetic resonance imaging (MRI). Besides its feasibility aspects that may influence quantitative analysis are studied. Eight FVB mice underwent cardiac MRI to determine stroke volumes and anatomic MRI as morphological reference for functional MPI data. Arrival time analyses of boli of 1 µl of 1 M superparamagnetic tracer were performed by MPI. Pulmonary transit time of the bolus was determined by measurements in the right and left ventricles. Pulmonary blood volume was calculated out of stroke volume, pulmonary transit time and RR-interval length including a maximal error analysis. Cardiac stroke volume was 31.7 µl ± 2.3 µl with an ejection fraction of 71% ± 6%. A sharp contrast bolus profile was observed by MPI allowing subdividing the first pass into three distinct phases: tracer arrival in the right ventricle, pulmonary vasculature, and left ventricle. The bolus full width at half maximum was 578 ms ± 144 ms in the right ventricle and 1042 ms ± 150 ms in the left ventricle. Analysis of pulmonary transit time revealed 745 ms ± 81 ms. Mean RR-interval length was 133 ms ± 12 ms. Pulmonary blood volume resulted in 177 µl ± 27 µl with a mean maximal error limit of 27 µl. Non-invasive assessment of the pulmonary blood volume in mice was feasible. This technique can be of specific value for evaluation of pulmonary hemodynamics in mouse models of cardiac dysfunction or pulmonary disease. Pulmonary blood volume can complement cardiac functional parameters as a further hemodynamic parameter.
- 1 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Open AccessPulmonary blood volume estimation in mice by magnetic particle imaging and magnetic resonance imaging
This methodical work describes the measurement and calculation of pulmonary blood volume in mice based on two imaging techniques namely by using magnetic particle imaging (MPI) and cardiac magnetic resonance imaging (MRI). Besides its feasibility aspects that may influence quantitative analysis are studied. Eight FVB mice underwent cardiac MRI to determine stroke volumes and anatomic MRI as morphological reference for functional MPI data. Arrival time analyses of boli of 1 µl of 1 M superparamagnetic tracer were performed by MPI. Pulmonary transit time of the bolus was determined by measurements in the right and left ventricles. Pulmonary blood volume was calculated out of stroke volume, pulmonary transit time and RR-interval length including a maximal error analysis. Cardiac stroke volume was 31.7 µl ± 2.3 µl with an ejection fraction of 71% ± 6%. A sharp contrast bolus profile was observed by MPI allowing subdividing the first pass into three distinct phases: tracer arrival in the right ventricle, pulmonary vasculature, and left ventricle. The bolus full width at half maximum was 578 ms ± 144 ms in the right ventricle and 1042 ms ± 150 ms in the left ventricle. Analysis of pulmonary transit time revealed 745 ms ± 81 ms. Mean RR-interval length was 133 ms ± 12 ms. Pulmonary blood volume resulted in 177 µl ± 27 µl with a mean maximal error limit of 27 µl. Non-invasive assessment of the pulmonary blood volume in mice was feasible. This technique can be of specific value for evaluation of pulmonary hemodynamics in mouse models of cardiac dysfunction or pulmonary disease. Pulmonary blood volume can complement cardiac functional parameters as a further hemodynamic parameter.
- 1 March 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (6) , 064001
Magnetic particle imaging for in vivo blood flow velocity measurements in mice
Magnetic particle imaging (MPI) is a new imaging technology. It is a potential candidate to be used for angiographic purposes, to study perfusion and cell migration. The aim of this work was to measure velocities of the flowing blood in the inferior vena cava of mice, using MPI, and to evaluate it in comparison with magnetic resonance imaging (MRI). A phantom mimicking the flow within the inferior vena cava with velocities of up to 21 cm s −1 was used for the evaluation of the applied analysis techniques. Time–density and distance–density analyses for bolus tracking were performed to calculate flow velocities. These findings were compared with the calibrated velocities set by a flow pump, and it can be concluded that velocities of up to 21 cm s −1 can be measured by MPI. A time–density analysis using an arrival time estimation algorithm showed the best agreement with the preset velocities. In vivo measurements were performed in healthy FVB mice ( n = 10). MRI experiments were performed using phase contrast (PC) for velocity mapping. For MPI measurements, a standardized injection of a superparamagnetic iron oxide tracer was applied. In vivo MPI data were evaluated by a time–density analysis and compared to PC MRI. A Bland–Altman analysis revealed good agreement between the in vivo velocities acquired by MRI of 4.0 ± 1.5 cm s −1 and those measured by MPI of 4.8 ± 1.1 cm s −1 . Magnetic particle imaging is a new tool with which to measure and quantify flow velocities. It is fast, radiation-free, and produces 3D images. It therefore offers the potential for vascular imaging.
- 1 March 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (6) , 064001
Magnetic particle imaging for in vivo blood flow velocity measurements in mice
Magnetic particle imaging (MPI) is a new imaging technology. It is a potential candidate to be used for angiographic purposes, to study perfusion and cell migration. The aim of this work was to measure velocities of the flowing blood in the inferior vena cava of mice, using MPI, and to evaluate it in comparison with magnetic resonance imaging (MRI). A phantom mimicking the flow within the inferior vena cava with velocities of up to 21 cm s −1 was used for the evaluation of the applied analysis techniques. Time–density and distance–density analyses for bolus tracking were performed to calculate flow velocities. These findings were compared with the calibrated velocities set by a flow pump, and it can be concluded that velocities of up to 21 cm s −1 can be measured by MPI. A time–density analysis using an arrival time estimation algorithm showed the best agreement with the preset velocities. In vivo measurements were performed in healthy FVB mice ( n = 10). MRI experiments were performed using phase contrast (PC) for velocity mapping. For MPI measurements, a standardized injection of a superparamagnetic iron oxide tracer was applied. In vivo MPI data were evaluated by a time–density analysis and compared to PC MRI. A Bland–Altman analysis revealed good agreement between the in vivo velocities acquired by MRI of 4.0 ± 1.5 cm s −1 and those measured by MPI of 4.8 ± 1.1 cm s −1 . Magnetic particle imaging is a new tool with which to measure and quantify flow velocities. It is fast, radiation-free, and produces 3D images. It therefore offers the potential for vascular imaging.
- 1 March 2017
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 27 (1) , 6-12
Magnetic resonance imaging for precise radiotherapy of small laboratory animals
- 1 March 2017
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 27 (1) , 6-12
Magnetic resonance imaging for precise radiotherapy of small laboratory animals
- 21 April 2015
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 187 (05) , 347-352
Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice
Purpose: Magnetic particle imaging (MPI) is a new radiologic imaging modality. For the first time, a commercial preclinical scanner is installed. The goal of this study was to establish a workflow between MPI and magnetic resonance imaging (MRI) scanners for a complete in vivo examination of a mouse and to generate the first co-registered in vivo MR-MP images. Materials and Methods: The in vivo examination of five mice were performed on a preclinical MPI scanner and a 7 Tesla preclinical MRI system. MRI measurements were used for anatomical referencing and validation of the injection of superparamagnetic iron oxide (SPIO) particles during a dynamic MPI scan. We extracted MPI data of the injection phase and co-registered it with MRI data. Results: A workflow process for a combined in vivo MRI and MPI examination was established. A successful injection of ferucarbotran was proven in MPI and MRI. MR-MPI co-registration allocated the SPIOs in the inferior vena cava and the heart during and shortly after the injection. Conclusion: The acquisition of preclinical MPI and MRI data is feasible and allows the combined analysis of MR-MPI information. Key Points: • The first commercial preclinical MPI system was installed and has been tested successfully in an in vivo experiment. • This MPI system can detect SPIO in vivo in a mouse model. • First time performance of a combined in vivo MPI-MRI examination. • Co-registered MR-MPI allows high temporal resolution imaging of the vascular SPIO distribution. Citation Format: • Kaul MG., Weber O, Heinen U et al. Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in a Mouse. Fortschr Röntgenstr 2015; 187: 347 – 352 Ziel: Magnetic particle imaging (MPI) ist ein neues Verfahren in der radiologischen Bildgebung und erstmalig wurde ein kommerzieller Scanner in einer präklinischen Variante installiert. Ziel der Studie war, einen Arbeitsablauf zwischen dem MPI System und einem präklinischen Magnetresonanztomografen zur vollständigen In-vivo-Untersuchung einer Maus zu etablieren und erstmalig co-registrierte In-vivo-MR-MP-Bilddaten zu erzeugen. Material und Methoden: Die Untersuchung an fünf Mäusen wurde an einem präklinischen MPI-Scanner und einem präklinischen 7-Tesla-MRT-System durchgeführt. Die MRT diente zur anatomischen Referenzierung und zur Validierung der Injektion von superparamagnetischen Eisenoxidpartikeln (SPIO) während einer dynamischen MPI-Messung. Die MPI-Daten der Injektionsphase wurden extrahiert und mit MR-Bildern co-registriert. Ergebnisse: Es konnte ein Arbeitsablauf für eine kombinierte präklinische In-vivo-MR-MPI Untersuchung etabliert werden. Eine erfolgreiche Injektion der SPIO konnte sowohl im MPI als auch im MRT nachgewiesen werden. Die MR-MPI-Co-Registrierung zeigte ein SPIO-Signal in der Vena cava inferior und dem Herzen während und nach der Injektion. Schlussfolgerung: Daten aus einer präklinischen MPI- und MRT-Untersuchung können gemeinsam erhoben und die kombinierte MPI-MR-Bildinformation betrachtet werden. Kernaussagen: • Der erste kommerzielle präklinische MPI-Tomograf wurde installiert und erfolgreich in einem in vivo Experiment getestet. • Dieses MPI-System erlaubt eine in vivo Detektion von SPIO in einem Mausmodell. • Erstmalige Durchführung einer kombinierten In-vivo-MR-MPI-Untersuchung. • Co-registiertes MP-MRI erlaubt eine zeitlich hochaufgelöste Abbildung der vaskulären SPIO-Biodistribution.
- 21 April 2015
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 187 (05) , 347-352
Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice
Purpose: Magnetic particle imaging (MPI) is a new radiologic imaging modality. For the first time, a commercial preclinical scanner is installed. The goal of this study was to establish a workflow between MPI and magnetic resonance imaging (MRI) scanners for a complete in vivo examination of a mouse and to generate the first co-registered in vivo MR-MP images. Materials and Methods: The in vivo examination of five mice were performed on a preclinical MPI scanner and a 7 Tesla preclinical MRI system. MRI measurements were used for anatomical referencing and validation of the injection of superparamagnetic iron oxide (SPIO) particles during a dynamic MPI scan. We extracted MPI data of the injection phase and co-registered it with MRI data. Results: A workflow process for a combined in vivo MRI and MPI examination was established. A successful injection of ferucarbotran was proven in MPI and MRI. MR-MPI co-registration allocated the SPIOs in the inferior vena cava and the heart during and shortly after the injection. Conclusion: The acquisition of preclinical MPI and MRI data is feasible and allows the combined analysis of MR-MPI information. Key Points: • The first commercial preclinical MPI system was installed and has been tested successfully in an in vivo experiment. • This MPI system can detect SPIO in vivo in a mouse model. • First time performance of a combined in vivo MPI-MRI examination. • Co-registered MR-MPI allows high temporal resolution imaging of the vascular SPIO distribution. Citation Format: • Kaul MG., Weber O, Heinen U et al. Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in a Mouse. Fortschr Röntgenstr 2015; 187: 347 – 352 Ziel: Magnetic particle imaging (MPI) ist ein neues Verfahren in der radiologischen Bildgebung und erstmalig wurde ein kommerzieller Scanner in einer präklinischen Variante installiert. Ziel der Studie war, einen Arbeitsablauf zwischen dem MPI System und einem präklinischen Magnetresonanztomografen zur vollständigen In-vivo-Untersuchung einer Maus zu etablieren und erstmalig co-registrierte In-vivo-MR-MP-Bilddaten zu erzeugen. Material und Methoden: Die Untersuchung an fünf Mäusen wurde an einem präklinischen MPI-Scanner und einem präklinischen 7-Tesla-MRT-System durchgeführt. Die MRT diente zur anatomischen Referenzierung und zur Validierung der Injektion von superparamagnetischen Eisenoxidpartikeln (SPIO) während einer dynamischen MPI-Messung. Die MPI-Daten der Injektionsphase wurden extrahiert und mit MR-Bildern co-registriert. Ergebnisse: Es konnte ein Arbeitsablauf für eine kombinierte präklinische In-vivo-MR-MPI Untersuchung etabliert werden. Eine erfolgreiche Injektion der SPIO konnte sowohl im MPI als auch im MRT nachgewiesen werden. Die MR-MPI-Co-Registrierung zeigte ein SPIO-Signal in der Vena cava inferior und dem Herzen während und nach der Injektion. Schlussfolgerung: Daten aus einer präklinischen MPI- und MRT-Untersuchung können gemeinsam erhoben und die kombinierte MPI-MR-Bildinformation betrachtet werden. Kernaussagen: • Der erste kommerzielle präklinische MPI-Tomograf wurde installiert und erfolgreich in einem in vivo Experiment getestet. • Dieses MPI-System erlaubt eine in vivo Detektion von SPIO in einem Mausmodell. • Erstmalige Durchführung einer kombinierten In-vivo-MR-MPI-Untersuchung. • Co-registiertes MP-MRI erlaubt eine zeitlich hochaufgelöste Abbildung der vaskulären SPIO-Biodistribution.
- 20 October 2004
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 176 (11) , 1560-1565
Evaluation of Balanced Steady-State Free Precession (TrueFISP) and K-space Segmented Gradient Echo Sequences for 3D Coronary MR Angiography with Navigator Gating at 3 Tesla
Ziel: Erprobung von k-Raum segmentierten Gradientenecho-Pulssequenzen für die frei geatmete Magnetresonanz-Koronarangiographie (cMRA) auf einem klinischen 3-Tesla (T)-System. Methoden: Es wurden T2-präparierte, fettsupprimierte Turbo-Field-Echo (TFE, turboFLASH, SFPGR) und balanced-TFE (b-TFE, TrueFISP, FIESTA, segmentierte SSFP) Sequenzen mit Navigator-Gating zur prospektiven Bewegungskorrektur auf einem 3T System, ausgestattet mit einer sechselementigen Phased-array-Spule, durchgeführt. Bei 15 gesunden Probanden wurde die rechte Koronararterie (RCA) mit der TFE und der b-TFE-Sequenz und aufgrund von Untersuchungszeitbeschränkungen bei 10 Probanden die linke Koronararterie (LM/LAD) ausschließlich mit der TFE Sequenz untersucht. Die Bildqualität wurde auf einer fünfstufigen Skala eingestuft (0 = nicht sichtbar bis 4 = exzellent). Die Längen, die Durchmesser und die Schärfe der Gefäße und das Kontrast-zu-Rausch-Verhältnis (CNR) wurden bestimmt. Ergebnisse: 98 % aller Hauptsegmente (proximales, mittleres, distales) der RCA konnten mit der TFE und 82 % mit der b-TFE gesehen werden. Die Bildqualität der drei Segmente war höher für die TFE (2,7/2,7/1,5) als für die b-TFE (1,9/1,6/0,9) mit p: (≤ 0,001/≤ 0,004/≤ 0,056). Die gemessene Gefäßlänge war länger für die TFE (95 ± 22 mm) als für die b-TFE (80 ± 40 mm; p ≤ 0,115). Es wurden keine signifikanten Änderungen (p ≤ 0,074, p ≤ 0,145) im Durchmesser und der Schärfe der RCAs zwischen der TFE (2,4 ± 0,3 mm, 60 % ± 5) und der b-TFE Sequenz (2,4 ± 0,3 mm, 62 % ± 6) beobachtet. Das CNR war höher für TFE (10,1 ± 3,4) als für b-TFE (6,6 ± 2,1; p ≤ 0,014). Alle zehn Hauptstämme und proximalen Segmente der LM/LAD, die nur mit der TFE-Sequenz untersucht wurden, waren sichtbar mit einer Bildqualität von 2,5 und 2,1. Das mittlere Segment war sichtbar in 7 Fällen mit einer Bildqualität von 1,3. In 3 Fällen war das distale Segment sichtbar mit einer Bildqualität von 0,5. Die Gefäßlänge betrug 78 ± 27 mm und das CNR 11,9 ± 2,4. Schlussfolgerungen: Die konventionelle TFE-Technik hat die Machbarkeit der cMRA bei 3T gezeigt. Die b-TFE ist in ihrer jetzigen Verfügbarkeit bei 3T der TFE-Sequenz unterlegen. Purpose: To test the feasibility of k-space segmented gradient-echo pulse sequences for free-breathing coronary magnetic resonance angiography (cMRA) on a clinical 3T system. Materials and Methods: T2-prepared, fat-suppressed turbo field echo (TFE, turboFLASH, SFPGR) as well as balanced TFE (b-TFE, trueFISP, FIESTA, segmented SSFP) sequences with navigator gating for prospective motion correction were applied on a 3T system equipped with a six-element phased-array cardiac coil. In 15 healthy volunteers, the right coronary artery (RCA) was examined with TFE and b-TFE sequences. Due to examination time limitations, the left coronary artery (LM/LAD) was examined exclusively with the TFE sequence in ten volunteers. Image quality was graded on a five point scale (0 = not visualized to 4 = excellent). The length, diameter and sharpness of the vessels and the contrast-to-noise ratios (CNR) were measured. Results: 98 % of all major segments (proximal/middle/distal) of the RCA could be seen with the TFE sequence and 82 % with the b-TFE sequence. The image quality for the three segments was graded higher for the TFE sequence (2.7/2.7/1.5) than for the b-TFE sequence (1.9/1.6/0.9) with P: (≤ 0.001/≤ 0.004/≤ 0.056). The kappa of the interobserver variability was 0.75 for the TFE sequence and 0.8 for the b-TFE sequence. The measured vessel lengths were longer for the TFE sequence (95 ± 22 mm) than for the b-TFE sequence (80 ± 40 mm; P ≤ 0.115). No significant changes (P ≤ 0.074, P ≤ 0.145) in diameter and vessel sharpness of the RCAs were observed between the TFE (2.4 ± 0.3 mm, 60 % ± 5) and b-TFE sequences (2.4 ± 0.3 mm, 62 % ± 6). The CNR was higher for the TFE sequence (10.1 ± 3.4) than for the b-TFE sequence (6.6 ± 2.1; P ≤ 0.014). All ten main and proximal segments of the LM/LAD, which were examined exclusively with the TFE sequence, were visible with grade 2.5 and 2.1. The middle segment was visible in seven cases with grade 1.3. In three cases, the distal segment was visible with grade 0.5. The vessel length was 78 ± 27 mm and the CNR 11.9 ± 2.4. Conclusion: The conventional TFE technique has demonstrated good feasibility for cMRA at 3T. In its operational availability at 3T, the b-TFE sequence is inferior to the TFE sequence.
- 20 October 2004
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 176 (11) , 1560-1565
Evaluation of Balanced Steady-State Free Precession (TrueFISP) and K-space Segmented Gradient Echo Sequences for 3D Coronary MR Angiography with Navigator Gating at 3 Tesla
Ziel: Erprobung von k-Raum segmentierten Gradientenecho-Pulssequenzen für die frei geatmete Magnetresonanz-Koronarangiographie (cMRA) auf einem klinischen 3-Tesla (T)-System. Methoden: Es wurden T2-präparierte, fettsupprimierte Turbo-Field-Echo (TFE, turboFLASH, SFPGR) und balanced-TFE (b-TFE, TrueFISP, FIESTA, segmentierte SSFP) Sequenzen mit Navigator-Gating zur prospektiven Bewegungskorrektur auf einem 3T System, ausgestattet mit einer sechselementigen Phased-array-Spule, durchgeführt. Bei 15 gesunden Probanden wurde die rechte Koronararterie (RCA) mit der TFE und der b-TFE-Sequenz und aufgrund von Untersuchungszeitbeschränkungen bei 10 Probanden die linke Koronararterie (LM/LAD) ausschließlich mit der TFE Sequenz untersucht. Die Bildqualität wurde auf einer fünfstufigen Skala eingestuft (0 = nicht sichtbar bis 4 = exzellent). Die Längen, die Durchmesser und die Schärfe der Gefäße und das Kontrast-zu-Rausch-Verhältnis (CNR) wurden bestimmt. Ergebnisse: 98 % aller Hauptsegmente (proximales, mittleres, distales) der RCA konnten mit der TFE und 82 % mit der b-TFE gesehen werden. Die Bildqualität der drei Segmente war höher für die TFE (2,7/2,7/1,5) als für die b-TFE (1,9/1,6/0,9) mit p: (≤ 0,001/≤ 0,004/≤ 0,056). Die gemessene Gefäßlänge war länger für die TFE (95 ± 22 mm) als für die b-TFE (80 ± 40 mm; p ≤ 0,115). Es wurden keine signifikanten Änderungen (p ≤ 0,074, p ≤ 0,145) im Durchmesser und der Schärfe der RCAs zwischen der TFE (2,4 ± 0,3 mm, 60 % ± 5) und der b-TFE Sequenz (2,4 ± 0,3 mm, 62 % ± 6) beobachtet. Das CNR war höher für TFE (10,1 ± 3,4) als für b-TFE (6,6 ± 2,1; p ≤ 0,014). Alle zehn Hauptstämme und proximalen Segmente der LM/LAD, die nur mit der TFE-Sequenz untersucht wurden, waren sichtbar mit einer Bildqualität von 2,5 und 2,1. Das mittlere Segment war sichtbar in 7 Fällen mit einer Bildqualität von 1,3. In 3 Fällen war das distale Segment sichtbar mit einer Bildqualität von 0,5. Die Gefäßlänge betrug 78 ± 27 mm und das CNR 11,9 ± 2,4. Schlussfolgerungen: Die konventionelle TFE-Technik hat die Machbarkeit der cMRA bei 3T gezeigt. Die b-TFE ist in ihrer jetzigen Verfügbarkeit bei 3T der TFE-Sequenz unterlegen. Purpose: To test the feasibility of k-space segmented gradient-echo pulse sequences for free-breathing coronary magnetic resonance angiography (cMRA) on a clinical 3T system. Materials and Methods: T2-prepared, fat-suppressed turbo field echo (TFE, turboFLASH, SFPGR) as well as balanced TFE (b-TFE, trueFISP, FIESTA, segmented SSFP) sequences with navigator gating for prospective motion correction were applied on a 3T system equipped with a six-element phased-array cardiac coil. In 15 healthy volunteers, the right coronary artery (RCA) was examined with TFE and b-TFE sequences. Due to examination time limitations, the left coronary artery (LM/LAD) was examined exclusively with the TFE sequence in ten volunteers. Image quality was graded on a five point scale (0 = not visualized to 4 = excellent). The length, diameter and sharpness of the vessels and the contrast-to-noise ratios (CNR) were measured. Results: 98 % of all major segments (proximal/middle/distal) of the RCA could be seen with the TFE sequence and 82 % with the b-TFE sequence. The image quality for the three segments was graded higher for the TFE sequence (2.7/2.7/1.5) than for the b-TFE sequence (1.9/1.6/0.9) with P: (≤ 0.001/≤ 0.004/≤ 0.056). The kappa of the interobserver variability was 0.75 for the TFE sequence and 0.8 for the b-TFE sequence. The measured vessel lengths were longer for the TFE sequence (95 ± 22 mm) than for the b-TFE sequence (80 ± 40 mm; P ≤ 0.115). No significant changes (P ≤ 0.074, P ≤ 0.145) in diameter and vessel sharpness of the RCAs were observed between the TFE (2.4 ± 0.3 mm, 60 % ± 5) and b-TFE sequences (2.4 ± 0.3 mm, 62 % ± 6). The CNR was higher for the TFE sequence (10.1 ± 3.4) than for the b-TFE sequence (6.6 ± 2.1; P ≤ 0.014). All ten main and proximal segments of the LM/LAD, which were examined exclusively with the TFE sequence, were visible with grade 2.5 and 2.1. The middle segment was visible in seven cases with grade 1.3. In three cases, the distal segment was visible with grade 0.5. The vessel length was 78 ± 27 mm and the CNR 11.9 ± 2.4. Conclusion: The conventional TFE technique has demonstrated good feasibility for cMRA at 3T. In its operational availability at 3T, the b-TFE sequence is inferior to the TFE sequence.